Updated 2026 survey of global online degrees and certificates in AI for pharmaceutical science. Compare programs by level, curriculum, cost, and duration – including new offerings from UCSF, Yale, and LIU.
An overview of OpenAI's open-weight GPT-OSS models. Examine their technical specifications, benchmark performance, gpt-oss-safeguard safety models, and applications for reasoning in healthcare.
Examines how AI accelerates the pharmaceutical drug pipeline, reducing time to market. Updated for 2026 with the latest clinical milestones, FDA guidance, and industry developments including Insilico Medicine's Phase IIa results and the Recursion-Exscientia merger.
Examines RegTech adoption challenges for emerging biotechs, focusing on cost, scalability, and AI-driven compliance. Covers flexible licensing, usage-based pricing, deferred-value models, and the latest platform innovations from Veeva Vault Basics and beyond.
An explanation of active learning principles and their adaptation for Large Language Models (LLMs) using human-in-the-loop (HITL) feedback for model alignment, including DPO, GRPO, and RLVR.
This article examines strategies for integrating content management systems like Box and Veeva Vault to overcome information silos in regulated environments.
An overview of the pharmaceutical industry's history, from 19th-century origins to the current global market size, sales figures, and regional distribution.
An explanation of regulatory requirements for audit trails under 21 CFR Part 11 and EU Annex 11, covering automation strategies, data integrity measures, and the latest 2025-2026 regulatory developments including the Annex 11 draft revision and FDA CSA guidance.
A comprehensive guide to MCP servers for Claude Code web search, including Brave Search, Perplexity Sonar, Bright Data, and Firecrawl. Updated for 2026 with MCP Tool Search, OAuth authentication, and managed configuration.
An explanation of a single source of truth (SSOT) for the pharmaceutical industry. Learn how an SSOT integrates data across the drug lifecycle to ensure consistency.
An analysis of how CRM systems support medical device firms in managing HCP relationships, sales pipelines, and maintaining strict regulatory compliance.
An analysis of AI code assistants in large codebases. Evaluates GitHub Copilot, Amazon Q Developer, Cursor, Claude Code, Tabnine, and others on accuracy, context handling, security, and IDE integration. Updated February 2026.
This report details how pharmaceutical companies use mobile apps for patient support, medication adherence, and data collection, including the 2023-2024 digital therapeutics shakeout, FDA regulatory updates through 2026, and emerging AI-powered engagement strategies.
An overview of Reinforcement Learning (RL) and RLHF. Learn how RL uses reward functions and how RLHF incorporates human judgments to train AI agents. Updated with 2025-2026 developments including DPO, GRPO, DeepSeek-R1, and GPT-5.
Explore a comprehensive comparison of Tableau and Power BI, analyzing market share, features, pricing, and adoption trends for data professionals. Updated with 2025-2026 data including Gartner MQ 2025, Forrester Wave Q2 2025, and April 2025 pricing changes.
A technical review of dedicated OCR engines not based on LLMs. Examines computer vision and sequence modeling architectures, performance, and applications.
Explore how ERP systems integrate biotech R&D, manufacturing, and finance, ensuring GxP compliance and traceability. Covers major and niche vendor solutions.
A technical guide to Reinforcement Learning from Human Feedback (RLHF). This article covers its core concepts, training pipeline, key alignment algorithms, and 2025-2026 developments including DPO, GRPO, and RLAIF.
This article details AI applications in pharmaceutical business intelligence, covering drug discovery, clinical trials, supply chain, real-world evidence, and market intelligence.
Examines Kimi K2, a trillion-parameter open-weight LLM from Moonshot AI. Learn its technical details, development background, and strategic context.
This article explains Integrated Business Planning (IBP) as a strategic imperative for the pharmaceutical industry, detailing its role in unifying cross-functional plans and decision-making.
Explore 21 CFR Part 11 compliance for electronic records, signatures, and AI in GxP. Covers key elements, FDA guidance (including finalized CSA and AI credibility framework), and controls for data integrity and audit-ready systems. Updated February 2026.
This article defines Sales Force Effectiveness (SFE) in the MedTech industry, explaining its strategic importance for optimizing performance and achieving growth in a competitive market.
Explore key software needs, technology stacks, and specific tools like AI-driven drug design and cheminformatics in pharmaceutical software development.
© 2026 IntuitionLabs. All rights reserved.
